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Abstract
Hypertension is fast becoming a major public health problem across sub-Saharan Africa. We sought to determine the prevalence of
high blood pressure (BP) and associated risk factors as indicator of preclinical hypertension in a rural Gambian population.
We analyzed data on 6160 healthy Gambians cross-sectionally. Attention was given to 5 to<18-year olds (N=3637), as data from
sub-Saharan Africa on this young age group are scarce. High BP was deﬁned as systolic blood pressure (SBP) above the 95th
percentile for age-sex speciﬁc height z scores in <18-year olds employing population-speciﬁc reference values. Standard high BP
categories were applied to ≥18-year olds.
In <18-year olds, the multivariable analysis gave an adjusted high BP prevalence ratio of 0.95 (95% conﬁdence interval [CI]
0.92–0.98; P=0.002) for age and 1.13 (95% CI 1.06–1.19; P<0.0001) for weight-for-height z score (zWT-HT); sex and hemoglobin
were not shown to affect high BP. In adults age 1.05 (95% CI 1.04–1.05; P<0.0001), body mass index z score 1.28 (95% CI
1.16–1.40; P<0.0001), hemoglobin 0.90 (95% CI 0.85–0.96; P<0.0001) and high fasting glucose 2.60 (95% CI 2.02–3.36; P<
0.0001, though the number was very low) were conﬁrmed as risk factors for high BP prevalence; sex was not associated.
The reported high BP prevalence and associated risk factors in adults are comparable to other studies conducted in the region.
The observed high BP prevalence of 8.2% (95% CI 7.4–9.2) in our generally lean young Gambians (<18 years) is alarming, given that
high BP tracks from childhood to adulthood. Hence there is an urgent need for further investigation into risk factors of pediatric high
BP/hypertension even in rural African settings.
Abbreviations: BP = blood pressure, BCCG = Box-Cox Cole and Green distribution, BMI; zBMI = body mass index; body mass
index z-score, BPCE = Box-Cox Power Exponential distribution, DBP = diastolic blood pressure, DFID = Department for
International Development, GAMLSS = generalized additive models for location, scale and shape, g/dL = grams per decilitre, high-
BP = high blood pressure, KEMReS = Keneba Electronic Medical Records System, kg/m2 = kilogramm per meter squared,
KWDSS = Kiang West Demographic Surveillance System, KWLPS = Kiang West Longitudinal Population Study, LMIC = low- and
middle-income country, min = minutes, mmHg = millimeter of mercury, mmol/l = millimoles per litre, MRC = Medical Research
Council, WT-HT; zWT-HT =weight-for-height; weight-for-height z score, P = P value, SBP = systolic blood pressure, WHO =World
Health Organization, Y = years.
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11. Introduction
Cardiovascular diseases are an increasing major public health
issue worldwide, a trend occurring at an alarming rate in low-
and middle-income countries (LMIC), with the morbidity burden
rising sharply.[1–3] High blood pressure (BP) and clinical
hypertension are major risk factors for cardiovascular diseases
(ischemic cardiomyopathy, stroke, and heart failure) and chronic
kidney disease,[4] and a leading cause of mortality world-
wide.[1,2,5] According to the WHO, 1 billion people (i.e., 40% of
people aged 25 years and above) are living with hypertension
with the prevalence highest in the African Region at 46%.[1] It is a
challenging task to compare hypertension prevalence in sub-
Saharan Africa from published data owing to both the scarcity,
especially in younger age groups, and the heterogeneity of studies,
with the prevalence of hypertension varying extensively between
and within studies.[6] As an example, national prevalence rates
range from 15.9% in Eritrea[7] to 39.6% in the Seychelles.[8] The
prevalence of hypertension may also be affected by locality. In a
study in Nigeria, the prevalence was signiﬁcantly higher among
urban (32.7%) compared to rural dwellers (12.9%).[9] However,
such differences are less marked in other countries like Ghana
being respectively 33.4% and 27.0%[10] and Ethiopia being
[11]
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nosed for years largely because of the absence of severe clinical
symptoms resulting in serious complications.[12] There is also
growing evidence suggesting that hypertension in adulthood has
its roots in childhood and adolescence.[13] This necessitates
population-based screening for early detection of those with high
(BP) and hypertension across all age groups. To date, data on
high BP/hypertension in children and adolescents in sub-Saharan
Africa are only available from a few sites including South Africa,
Nigeria, Congo, Uganda, and Ghana.[14–19] The majority of these
are set in urban areas where the epidemiological transition from
communicable to noncommunicable disease (including cardio-
vascular diseases) is more advanced, with less active and
unhealthier lifestyles compared to rural areas.
There is a paucity of data on hypertension and its related risk
factors in The Gambia. Indeed, population-based studies with a
comparison between urban and rural sites were published 10 to
20 years ago, when the nationwide prevalence of hypertension
was found to be around 24% in adults, with slightly lower rates
in rural areas.[20–22] A more recent study including urban adults
from The Gambia and Sierra Leone reported a much higher
overall prevalence of 44.8%.[23] This may be because of the speed
at which the epidemiological transition is occurring. There is no
large comprehensive recent study on hypertension including
pediatric hypertension in Gambia or elsewhere in rural Africa as
far as we are aware. The present study was carried out to
investigate the prevalence of high BP and associated risk factors
for hypertension in >6000 healthy rural Gambians aged 5 years
and older. We gave particular attention to<18-year olds, as data
on this age group are very scarce and has to our knowledge not
previously been reported in a systematic manner in this rural sub-
Saharan setting. High BP tracks from childhood to adulthood
and raised BP in this younger age group can be viewed as
indication of preclinical hypertension, which may lead to
substantial negative health consequences later in life.2. Materials and methods
2.1. Study population and data sources
This study was conducted within the Kiang West Longitudinal
Population Study (KWLPS) cohort in The Gambia,[24] which
captures >14000 residents across 36 villages within the rural
Kiang West District, served by the Medical Research Council
(MRC) Keneba ﬁeld station. Relevant data for these analyses
primarily originated from the Keneba Biobank (http://ing.mrc.ac.
uk/home/research-areas/the-keneba-biobank/), with BP, anthro-
pometric and hematological measures, and questionnaire data
collected between May 2012 and October 2014. Demographic
and clinical data were available via linkage with the Kiang West
Demographic Surveillance System (KWDSS) and Keneba Elec-
tronic Medical Records System (KEMReS) databases.[24] The
population comprises socially homogenous, rural subsistence
farmers, of whom >95% are Mandinka (self-reported ethnicity);
ethnicity was therefore not considered as covariate in our
analyses. Sibship was determined by shared maternal ID to
account for relatedness within the population, as this society is
polygamous and characterized by a complex pedigree structure,
for example, the presence of a large proportion of half-sibs
(Supplementary Table 1, http://links.lww.com/MD/B610). Chil-
dren younger than 5 years were not considered in these analyses,
as no BP measure was available for this age group. Individuals
with active infection (positive malaria rapid test of blood ﬁlm,2N=2) and those not fasted at blood collection (N=15) were also
dropped from the analyses. This research was approved by the
joint Gambia Government/MRC Ethics Committee and all
participants and/or legal guardians provided written, informed
consent.2.2. Deﬁnitions for outcome measures and covariates
All anthropometric measurements were conducted by trained
ﬁeld assistants using equipment calibrated daily. Height was
measured without footwear or headwear with the participants
standing fully erect against a stadiometer with the measurement
to the nearest 0.1cm. Weight was measured to the nearest 10g
using portable weighing scales (Tanita WB100, Tokyo, Japan)
and body composition using a digital bioimpedance analysis scale
(Tanita, Tokyo, Japan). Body mass index (BMI) was calculated in
those 18 years of age or older as weight in kilograms divided by
height in metres squared. Based on BMI, individuals were
classiﬁed using standard cut-offs as underweight (<18kg/m2),
normal weight (18–24.9kg/m2), overweight (25–29.9kg/m2),
and obese (≥30kg/m2). As BMI is strongly age-dependent below
the age of 18 years, we deemed internally calibrated weight-for-
height z scores (zWT-HT) as best measure of body composition in
our population. The zWT-HT and zBMI were calculated as
previously described.[25,26]
Hemoglobin was measured by Medonic M-series 3-part
hematology analyser (Boule Medical) or HemoCue. Anemia
was deﬁned using WHO criteria (Supplementary Table 2, http://
links.lww.com/MD/B610).[27]
BP was recorded in triplicate (separated by 5minutes) with an
Omron 705IT machine (Omron, Kyoto, Japan) according to the
manufacturer instruction with the participant in a seated position
and the participant’s arm positioned at heart level. The ﬁrst
measurement was discarded to eliminate error that may occur
because of stress or excitement during the ﬁrst measurement and
the average of the second and third BP measurements was used
for further analyses. The mean BP measurement, determined
cross-sectionally at one time point, was employed to deﬁne high
BP as primary outcome, rather than hypertension per se, as the
latter requires repeat measures at separate time points.
As our rural Gambian population covered a wide spectrum of
age, sex, and height, we estimated reference values of 50th, 90th,
95th, and 99th percentiles for SBP and DBP by age and height (at
the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles) for
boys and girls aged 5 to <18 years (Supplementary Table 3,
http://links.lww.com/MD/B610). High BP in those aged 5 to<18
years was then deﬁned as the average systolic BP (SBP) and/or
diastolic BP (DBP) that is ≥95th percentile for sex, age, and age-
sex speciﬁc height z scores in our own population (see statistical
methods below and Supplementary Materials for details, http://
links.lww.com/MD/B610). Note that this high BP deﬁnition
broadly follows the guidelines for deﬁnition of hypertension as
stipulated by the National High Blood Pressure Education
Program Working Group on High Blood Pressure in Children
and Adolescents (hereafter referred to as the 4th Report).[28] For
those ≥18 years, high BP was deﬁned as SBP ≥140mmHg and/or
diastolic blood pressure (DBP) ≥90mmHg and/or receiving
treatment for hypertension in the 3 months before BP measure-
ment and/or being diagnosed as hypertensive in MRC Keneba
clinical database.[29] Those who had stated to receive hyperten-
sion treatment from elsewhere than the MRC Keneba clinic were
excluded (N=24), as we had no means to verify the details of
their prescription. Furthermore, as pregnancy affects BP
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measured during this period (i.e., who gave birth in the time
frame of 7 weeks before BP measurement or up to 20 weeks after
it [N=134]). Those with missing information on BP were also
excluded from the analyses (N=7).
Those at risk of having diabetes (high fasting glucose/diabetes)
were identiﬁed based on a fasting plasma glucose level of >7
mmol/L measured by Accu Check (Roche Diagnostics) or
receiving diabetes medication from the MRC Keneba clinic
where the drugs supplied are Glibenclamide and Metformin.
None of our participants stated to receive diabetes treatment
from elsewhere than the MRC Keneba clinic.
Information on education was available for those aged ≥18
years; a participant was deﬁned to be educated if s/he had
attended at least primary school.2.3. Statistical analyses
First, we plotted the distribution of SBP and DBP for the whole
study population (N=6160) by age and sex employing a cubic
spline regression (Fig. 1), accounting for relatedness by sibship (i.e.,
shared mother; see above and Supplementary Table 1, http://links.
lww.com/MD/B610). All statistical analyses were stratiﬁed by age
(5 to<18 years and ≥18 years) because we applied different body
composition measures (internal zWT-HT and zBMI, respectively)
anddifferentdeﬁnitionsofhighBP in these2agegroups (see above).
We computed zBMI and constructed age- and sex-dependent
growth curves for BMI for the≥18-years olds using the generalized
additivemodels for location, scale, and shape (GAMLSS)withBox-
Cox Power Exponential (BPCE) distribution.[30,31] The GAMLSS
models are widely used for constructing growth percentiles
curves.[32–34] As internal zWH-HT and zBMI are both age- and
sex-independent and normalized, each was divided into quartiles.Figure 1. Systolic and diastolic blood pressure (SBP and DBP) in rural Gambian m
DBP (grey dots) by age and sex for the whole study population (N=6160); orange
red line represents the mean. The dashed line represents age 18 years, above and
materials and methods section. DBP=diastolic BP, SBP=systolic BP.
3Second, we estimated age- and sex-speciﬁc height z scores
using GAMLSS with Box-Cox t-distribution where the
mean, coefﬁcient of variation, skewness, and kurtosis were
modeled as nonparametric smoothing cubic spline functions
of age. Next, we computed the 95th percentiles for SBP and
DBP by sex for children aged 5 to <18 years using Box-Cox
Cole and Green (BCCG) distribution with the mean values of
SBP and DBP as function of a smoothing cubic spline of age
and height z scores.[35] These 95th percentiles were used to
deﬁne high BP in 5 to <18 year olds[28] as outlined above.
Further details are shown in the Supplementary materials
including Supplementary Tables 3 and 4, http://links.lww.
com/MD/B610.
We next compared the sex, educational level, and high fasting
glucose/diabetes status between those with high BP and those
within the normal range of BP using Wald-adjusted test
accounting for clustering by sibship. Both zWT-HT and zBMI,
which were normally distributed, were compared between the
high BP and normal range BP groups using Wald-adjusted test,
whereas age, weight, height, BMI, SBP, DBP, and hemoglobin
levels, which were skewed, were compared using Somers’ D
statistics, which is a nonparametric measure of association and
allows accounting for relatedness by sibship.[36,37] We contin-
ued by estimating the prevalence of high BP stratiﬁed by age, sex,
and anemia category. Finally, univariable and multivariable
Poisson regressions were performed with clustered sandwich
estimator accounting for relatedness by sibship. Age, sex, zWT-
HT or zBMI, high fasting glucose/diabetes status, and
hemoglobin level were investigated as potential risk factors.
Explanatory variables associated with high BP at 10%
signiﬁcance level were included in the multivariable analysis.
The GAMLSS was performed using the package GAMLSS in
R[38] and other analyses done in Stata 13.1.ales and females. Cubic spline ﬁt was employed to plot SBP (black dots) and
and green thin lines indicate the 95% upper and lower boundaries and the thick
below of which we applied different criteria to deﬁne high BP as outlined in the
[28]
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3.1. Study population summary statistics
Summary statistics on the study population by age group and
association of high BP with demographic, anthropometric, and
clinical characteristics are given in Table 1. Of 6160 study
participants, 3637 were aged 5 to <18-years old and 2523 aged
18 years and older. There is a preponderance of women (>70%)
in the adult population because of outmigration of males for
work purposes in this region. Information on mother’s ID was
not available for 568 (27.9%) individuals aged 5 to <18 years
and 1309 (59.1%) individuals aged ≥18 years; these were treated
as singletons in our analyses (Supplementary Table 1, http://links.
lww.com/MD/B610).
The distribution of SBP and DBP by age and sex indicated
slight differences between males and females, and a steady
increase in BP measures across all ages (Fig. 1). We provide here
for the ﬁrst time the estimated population-speciﬁc reference
values of 50th, 90th, 95th, and 99th percentiles for SBP and DBP
by age and height (at the 5th, 10th, 25th, 50th, 75th, 90th, and
95th percentiles) for boys and girls aged 5 to <18 years in rural
Gambia (Supplementary Table 3, http://links.lww.com/MD/
B610). The population-speciﬁc 95th BP percentile was used as
basis for the determination of high BP in our Gambian children
and adolescents, broadly following the guidelines for hyperten-
sion deﬁnition in the 4th Report. Although our high BP and the
hypertension categories as stipulated by the 4th Report are not
directly comparable, we show for information purposes our
population-speciﬁc estimates of age, sex, and age- and sex-
speciﬁc BP alongside the SBP and DBP 95th percentiles from the
4th Report[28] in Supplementary Table 5, http://links.lww.com/
MD/B610 and as 3D plots (Supplementary Figure 1, http://links.
lww.com/MD/B610). These indicate that our SBP and DBP
percentiles by sex, age, and age- and sex-speciﬁc height percentile
were generally lower in our Gambian population than those inTable 1
Summary statistics on rural Gambian study population by age gro
anthropometric, and clinical characteristics.
5 to <18 y of age
High BP
(n=300)
Normal ra
BP (n=33
Demographic characteristics
Female, n (%) 137 (45.7) 1593 (47.7)
Age in y, median (range) 9.5 (5–17.9) 10.6 (5–17.
Educated
∗
, n (%) n/a n/a
Anthropometric characteristics
Weight, kg, median (range) 24.6 (11.7–75.8) 26.7 (11.4–
Height in cm, median (range) 130.4 (97–191.5) 135.0 (93.9–
zWT-HT, mean (SD) 0.05 (1.34) 0.28 (1.01)
BMI, kg/m2, median (range) n/a n/a
zBMI, mean (SD) n/a n/a
Clinical characteristics
SBP, mmHg, median (range) 118.8 (96–155.5) 101.5 (67.5–
DBP, mmHg, median (range) 76.0 (44.5–101.5) 59.0 (37–82
Hemoglobin, g/dL, median (range) 12.0 (5–15.9) 11.9 (5.9–1
High fasting glucose/diabetes status†, n (%) 0 (0.0) 3 (0.09)
BMI=body mass index calculated for those ≥18 years, DBP=diastolic blood pressure, high BP=high blo
Tables 3 and 4, http://links.lww.com/MD/B610), P=P value, SBP= systolic blood pressure, y= years, zBM
score calculated in <18-y olds only.
∗
A participant was deﬁned to be educated if s/he attended at least primary school.
† High fasting glucose/diabetes status was deﬁned using a fasting glucose cut-off of >7mmol/L.
4the 4th Report (representing data from a mixed-ethnicity US
population), particularly in boys.
In adults aged 18 years and older, BP increased with age as
expected, with higher measures in females compared to males as
indicated in Figure 1.
3.2. Analysis of high BP prevalence by covariates
Association analyses of individual covariates (employed as
categorical variables) with high BP demonstrated correlations
with demographic and most clinical parameters, but not
anthropometric characteristics as shown in Table 1.i)up
nge
37)
9)
89.1
187
131
)
7.0)
od p
I=B5 to <18-year olds: In this age group 1730 (47.6%) were
females, with similar proportion of females among those with
high BP and normal BP (45.7% vs. 47.7%, P=0.48). Those
with high BP were younger than those not affected by high BP
(median [range]=9.5 and 10.6, respectively, P=0.001).
The zWT-HT was also higher in those with high BP (mean
[SD]=0.05 [1.3] vs.0.28 [1.0], P=0.004). Both high and
normal BP groups had similar hemoglobin levels (median
[range]=12 [5–15.9] vs. 11.9 [5.9–17.0] g/dL, P=0.11).
Three individuals with high fasting glucose/diabetes were
observed in the young age group, although none were
observed to have high BP.
≥18-year olds: This age group (N=2523) comprised moreii)
women than men; sex was not associated with high BP. The
median age of those with high BP was almost 20 years more
than those within the normal BP range (median [range]=59.5
[18.2–91.1] vs. 38.3 [18–100.1] years, P<0.0001). BMI was
slightly higher in high BP than in the comparative lower BP
group (median [range]=21.6 [13.1–39.2] vs. 20.6 [12.5–41.7]
kg/m2, respectively, P<0.0001); likewise, zBMI was higher in
those with high BP (mean [SD]=0.23 [1.1] vs.0.05 [1.0], P<
0.0001). Only 525 (20.8%) of our adult participants had
received some level of education and we observed fewerand association of high blood pressure with demographic,
≥18 y of age
P
High BP
(n=462)
Normal range
BP (n=2061) P
0.48 342 (74.0) 1,463 (71.0) 0.18
0.001 59.5 (18.2–91.1) 38.3 (18–100.1) <0.0001
n/a 22 (4.8) 503 (24.4) <0.0001
) 0.02 56.3 (33–115.2) 54.8 (30.3–111) 0.07
.7) 0.001 160 (140.5–194.3) 162.5 (139.4–194.4) <0.0001
0.004 n/a n/a n/a
n/a 21.6 (13.1–39.2) 20.5 (12.5–41.7) <0.0001
n/a 0.23 (1.05) 0.05 (0.98) <0.0001
) <0.0001 139.8 (87.5–239) 113.0 (80.5–218) <0.0001
<0.0001 79.0 (49.5–125.5) 69.0 (44–121.5) <0.0001
0.11 11.9 (7–17.2) 12.1 (5.1–17.3) 0.004
0.08 15 (3.2) 3 (0.1) 0.0002
ressure (for deﬁnition please see main text and Supplementary Materials including Supplementary
MI z score calculated in ≥18-y olds only (for details see main text), zWT-HT=weight-for-height z
Table 2
Prevalence of high blood pressure in rural Gambians stratiﬁed by age, sex, anthropometric trait, and anemia status.
Prevalence of high BP, % (95% CI)
5 to <18 y of age (N=3637) ≥18 y of age (N=2523)
Male Female All Male Female All
Overall 8.5 (7.4–9.9) 7.9 (6.7–9.3) 8.2 (7.4–9.2) 16.7 (14.1–19.6) 18.9 (17.2–20.9) 18.3 (16.8–19.9)
Age group
5–9 10.1 (8.3–12.3) 9.4 (7.6–11.6) 9.8 (8.5–11.3) n/a n/a n/a
10–17 7.0 (5.6–8.8) 6.7 (5.2–8.5) 6.9 (5.8–8.1) n/a n/a n/a
18–29 n/a n/a n/a 1.0 (0.02–3.8) 3.6 (2.2–5.7) 2.8 (1.8–4.4)
30–39 n/a n/a n/a 3.4 (1.1–10.1) 11.1 (8.4–14.5) 9.8 (7.4–12.7)
40–49 n/a n/a n/a 9.6 (5.2–17.0) 15.4 (12.1–19.7) 14.2 (11.2–17.7)
50–59 n/a n/a n/a 18.3 (12.6–25.8) 28.3 (23.0–34.1) 25.0 (20.9–29.6)
60–69 n/a n/a n/a 35.2 (27.3–44.0) 52.7 (45.5–59.7) 45.7 (40.2–51.3)
70–79 n/a n/a n/a 55.3 (41.1–68.8) 52.9 (41.2–64.2) 53.8 (44.7–62.7)
≥80 n/a n/a n/a 57.9 (35.6–77.4) 45.8 (27.5–65.4) 51.2 (36.5–65.6)
zWT-HT
∗
<0.68 6.6 (4.8–8.9) 6.3 (4.5–8.6) 6.4 (5.1–8.0) n/a n/a n/a
0.68–0 7.6 (5.7–9.9) 7.6 (5.6–10.1) 7.6 (6.1–9.3) n/a n/a n/a
0–<0.68 9.4 (7.1–12.4) 8.9 (6.5–12.1) 9.2 (7.5–11.3) n/a n/a n/a
>0.68 14.0 (10.1–19.2) 11.4 (7.7–16.7) 12.8 (10–16.4) n/a n/a n/a
BMI, kg/m2†
Underweight n/a n/a n/a 16.0 (14.6–21.7) 14.0 (10.6–18.2) 14.8 (12.0–18.1)
Normal n/a n/a n/a 15.1 (12.1–18.6) 17.7 (15.6–20.0) 16.9 (15.2–18.9)
Overweight n/a n/a n/a 32.6 (20.3–47.7) 28.0 (22.7–33.9) 28.6 (23.7–34.1)
Obese n/a n/a n/a 75.0 (23.8–96.7) 34.5 (22.9–48.4) 37.3 (25.7–50.6)
Anemia‡
Normal 9.5 (7.8–11.5) 8.5 (6.9–10.3) 9.0 (7.8–10.4) 11.3 (8.6–14.9) 17.8 (15.1–20.9) 15.4 (13.3–17.7)
Mild 6.1 (4.3–8.8) 4.3 (2.6–7.2) 5.4 (4.0–7.3) 21.0 (16.1–27.0) 18.3 (15.2–21.9) 19.1 (16.4–22.2)
Moderate or severe 7.0 (4.5–10.7) 7.5 (4.7–11.9) 7.2 (5.3–9.9) 26.8 (15.5–42.3) 17.6 (14.3–21.5) 18.4 (15.1–22.1)
BMI=body mass index calculated for those ≥18 years, CI= conﬁdence interval, y= years, zWT-HT=weight-for-height z score calculated in 5 to <18 y of age only.
∗
For zWT-HT, we used the z statistics that divide a Gaussian distribution into quartiles (25% are <0.68, 25% between 0.65 and 0, 25% between 0 and 0.68, and 25% >0.68)
† BMI categories: underweight (<18.5 kg/m2), normal (18.5 kg/m2 BMI <25kg/m2), overweight (25 kg/m2  BMI <30kg/m2), and obese (BMI ≥30kg/m2).
‡ Anemia was deﬁned as described in the Supplementary materials and methods, http://links.lww.com/MD/B610.
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[4.8%] vs. 525 [24.4%], P<0.0001). Hemoglobin levels were
slightly lower in those with high BP (median [range]=11.9
(7–17.2) g/dL) versus those with normal BP (median [range]=
12.1 [5.1–17.3] g/dL, P=0.004). A total of 18 individuals with
high fasting glucose/diabetes were observed, 15 (3.2%) among
the high BP and 3 (0.1%) among lower BP groups (P=
0.0002).
Estimated prevalence and 95% conﬁdence interval of high
BP by age group, sex as well as zWT-HT quartile or BMI
category, and anemia category are shown in Table 2. As only
21 individuals with high fasting glucose/diabetes were
identiﬁed in our population, the estimated effect of this risk
factor on high BP is unlikely to be reliable. However, we
decided not to exclude these individuals from any further
analyses, as this study reports population-speciﬁc determinants
of high BP.i) 5 to<18-year olds (Table 2): The prevalence of high BP in this
age group was 8.2% (95% conﬁdence interval [CI]: 7.4–9.2)
and comparable in females (7.9% [95% CI: 6.7–9.3]) and in
males (8.5% [95% CI: 7.4–9.9]). Children aged 5 to 9 years
appeared to present more frequently with high BP (prevalence
9.8% [95% CI: 8.5–11.3]) than those aged 10 to 18 years
(prevalence 6.9% [95% CI: 5.8–8.1]).
≥18-years olds (Table 2): In those aged 18 years or above, theii)
prevalence of high BP was 18.3% (95% CI: 16.8–19.9), and
slightly higher in females than in males (18.9% [95% CI:517.2–20.9] and 16.7% [95% CI: 14.1–19.6], respectively). In
both males and females, the prevalence of high BP increased
with age.
3.3. Univariable and multivariable analyses
All univariable and multivariable models were performed with
continuous explanatory variables with exception of sex and high
fasting glucose/diabetes status. Education was not considered in
the univariable and multivariable analyses, as we observed a
strong association between age and education (P<0.0001,
Supplementary Table 6, http://links.lww.com/MD/B610).i) 5 to <18-year olds (Table 3): The univariable analyses
demonstrated an increase in risk of high BP with higher zWT-
HT (P<0.0001) and surprisingly a slightly reduced risk with
increasing age (P<0.0001), but no evidence of association
with hemoglobin level (P=0.16). There was also no evidence
of difference in the risk of high BP between males and females
(P=0.48) in children and adolescents. High fasting glucose/
diabetes was not assessed because there were only 3
individuals affected by this risk factor in this age group.
The multivariable analysis therefore included age and zWT-
HT but not sex and hemoglobin and gave comparable
adjusted prevalence ratios as seen in the univariable analysis.
≥18-year olds (Table 3): In adults we assessed age, high fastingii)
glucose/diabetes status, zBMI, hemoglobin level, and sex in the
univariable analyses, with the former four being associated
with high BP. These variables were hence included in the
Table 3
Risk factors of high blood pressure in rural Gambians aged 5 to <18 years and 18 years or above.
Unadjusted PR (95% CI) P Adjusted PR (95% CI) P
5 to <18 y olds
∗
Age, y 0.95 (0.92–0.98) 0.001 0.95 (0.92–0.98) 0.002
zWT-HT 1.13 (1.07–1.19) <0.0001 1.13 (1.07–1.19) <0.0001
Sex (ref.: male)
Female 0.93 (0.75–1.15) 0.48 — —
Hemoglobin, g/dL 1.09 (0.97–1.23) 0.16 — —
18-y old or above†
Age, y 1.05 (1.04–1.05) <0.0001 1.05 (1.04–1.05) <0.0001
High fasting glucose/diabetes status‡ (ref.: No)
Yes 4.67 (3.73–5.84) <0.0001 2.60 (2.02–3.36) <0.0001
zBMI 1.26 (1.16–1.37) <0.0001 1.28 (1.16–1.40) <0.0001
Hemoglobin, g/dL 0.92 (0.87–0.97) 0.002 0.90 (0.85–0.96) 0.001
Sex (ref.: male)
Female 1.13 (0.94–1.37) 0.19 — —
CI= conﬁdence interval, P=P value, PR=prevalence ratio, y= years, zBMI=BMI z score, zWT-HT=weight-for-height z score. We stratiﬁed the cohort into those<18 y and those ≥18 y of age as different body
composition measures were applied in these age groups (internal zWT-HT and zBMI, respectively).
∗
N=3637.
† N=2523.
‡ Those with high fasting glucose/diabetes status (N=21) were categorized based on a fasting glucose cut-off of >7mmol/L.
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high BP with age as expected and about 3-fold higher risk in
high fasting glucose/diabetes (however, there were only 21
affected by this risk factor in adults).
4. Discussion
In The Gambia, population-based data from over a decade ago
reported prevalence rates for hypertension in >15-year olds of
around 24% (based on BP ≥140/90mmHg), with slightly
reduced levels observed in rural groups.[20,22] Given the rise of
noncommunicable diseases including cardiovascular disease in
sub-Saharan Africa and the increased risks to health in the
context of infectious comorbidities in this region,[39] it is essential
to assess children and adolescents as target group for the
evaluation of risk factors and health intervention. With this in
mind we analyzed BP data on rural Gambians from the Kiang
West Longitudinal Population Study (KWLPS) cohort[24] in The
Gambia, served by the MRC Keneba ﬁeld station. This included
>6000 rural Gambians across all ages above 5 years, for whom
BP measurements were collected as part of the Keneba Biobank
(http://ing.mrc.ac.uk/home/research-areas/the-keneba-biobank/)
and paid particular attention to those younger than 18 years of
age. We constructed reference percentiles for BP by sex, age, and
height in Gambians aged 5 to <18-year for the ﬁrst time
(Supplementary Table 3, http://links.lww.com/MD/B610), with
those with SBP above the 95th percentile for age, sex, and height
categorized as “high BP." Our high BP cutoff reference values are
overall lower than the US 4th Report norms,[28] particularly in
boys. Although our high BP and the 4th Report hypertension
groups are not directly comparable for reasons outlined above,
we considered BP reference standards represented in this study
more applicable to identify individuals with high BP among
Gambian children and adolescents. For those aged 18 years and
above, we applied the deﬁnition of high BP as those with BP
>140/90 and/or on hypertensive treatment and/or with recorded
hypertension diagnosis in our clinical database. We employed
different covariates of body composition (zWT-HT vs. BMI) in
the children and adolescents versus adults (≥18 years), as BMI is
strongly age-dependent below the age of 18 years (as outlined in6the methods section). To summarize, across all ages our high BP,
outcome measure is based on a cross-sectional assessment of BP,
and it does reﬂect a clinical diagnosis of hypertension; however,
high BP can be viewed as preclinical indication of hypertension.
Our analyses resulted in some surprising ﬁndings.We observed
a higher prevalence of high BP of 9.8% in 5 to 9-year olds
compared to 6.9% in those aged 10 to<18 years; in all<18-year
olds the proportion of high BP was greater among the girls
(Table 2).We do not deem this to be owing tomeasurement error,
as we measured BP in triplicate and excluded the ﬁrst
measurement to avoid “white coat" bias and all measurements
were taken by trained ﬁeld assistants in the ﬁeld (not wearing a
white coat), rather than a clinic environment. However, we
cannot exclude the possibility that particularly the youngest
study participants were more intimidated leading to slightly
inﬂated BP values. Our ﬁnding may also be inﬂuenced by the age-
sex-height distribution in 5 to 9-year olds, wherein growth
restriction because of malnutrition and infection in earlier life is
more evident than in 10 to 18-year olds, who have had more time
for catch-up growth.
Following on from this, our multivariable models revealed
associations with substantially increased risk of high BP for
females and slightly increased risk in those with higher zWT-HT
and decreased risk by age, respectively, in the <18-year olds. We
do as of yet not have an explanation for this ﬁnding; however, we
propose that these ﬁndings in children and adolsecents warrant
further investigation. Our data are in line with our previous study
in the same population which collected data on cardiovascular
risks in adolescents (N=1317, aged 14.1±1.5y) as part of a
follow-up study on maternal nutritional supplementation.[40]
This study showed that 8.5% of boys and 7.9% of girls were
hypertensive, deﬁned as SBP above the 95% percentile for height
and age in our rural Gambian population. A cross-sectional
survey in schoolchildren in Uganda also demonstrated high BP to
be associated with female sex and zBMI, as well as age[18] and
higher prevalence of hypertension in girls was likewise seen in
South Africa and Nigerian children/adolescents with higher body
mass and/or living in more urban environments.[15,16,41] The
studies in children in Uganda, South Africa, and Nigeria all
appear to apply the internationally used US 4th Report[28]
Jobe et al. Medicine (2017) 96:13 www.md-journal.comnormograms to identify hypertensives in their children and
adolescents. However, it is of note that, like in our present study,
although BP was measured multiple times, these measurements
were not always conducted on different occasions and therefore
the designation as hypertensive in these studies is not necessarily
in line with the 4th Report[28] or represents a clinical diagnosis of
hypertension. Having analyzed for the ﬁrst time the whole
spectrum of ages 5 to <18 years in a large proportion of our
Gambian population and applying our own population-speciﬁc
95th percentile reference cut-offs to deﬁne high BP (following
broadly the 4th Report[28] guidelines), we deem such population-
speciﬁc reference values more appropriate, as age, sex, and height
percentiles used to determine BP percentiles differ between
populations in LMIC including in sub-Saharan Africa and those
observed in US children. This echoes the conclusion made by
colleagues investigating pediatric hypertension in Iran.[42]
In the adult age groups (≥18 years), high BP prevalence was
shown to rise with age and tends to be more frequently seen in
men compared to women, as expected. The multivariable
analyses considered age, sex, zBMI, and high fasting glucose/
diabetes status, all of which were associated with high BP,
although zBMI only marginally and the number of those with
high fasting glucose/diabetes were very low. These data are
comparable to other studies conducted previously in The Gambia
and elsewhere in the region.
There are some limitations to our analyses. Several risk factors
including smoking, salt and alcohol intake, education, breast-
feeding, prepubertal stage, family history, diabetes, and infection
could be considered in the context of high BP/hypertension
particularly in adult populations. We had no or limited data
available on these as part of this study. Smoking is considered a
risk factor for cardiometabolic disease (though not hyperten-
sion). The prevalence of smokers in rural Gambia was previously
reportedly as 42% in men and 6% in women.[43] However,
anecdotally we believe the prevalence of smoking to be lower in
the rural Kiang West district and thus to be a less relevant risk
factor, particularly in women. Alcohol intake is negligible in our
predominantly Muslim population. Salt is added as an ingredient
of most dishes; however, how much of this is consumed on
average per person is difﬁcult to assess. This would be an
interesting area to explore further, particularly in view of salt-
sensitive hypertension, which is known to be more prevalent in
African ancestry population and is in part owing to genetic
factors.[44] We had data on education only in those aged ≥18
years and applied a crude binary measure of with/without
education based on attendance at primary school at least for our
exploratory analyses. Education was found to be highly
associated with age (as expected, Supplementary Table 6,
http://links.lww.com/MD/B610) and we thus dropped education
from all further analyses. Breastfeeding is considered to have a
beneﬁcial effect on lowering of later BP.[45] In The Gambia,
exclusive breastfeeding for the ﬁrst 6 months of age is strongly
promoted both by the government and the MRC and practiced
routinely; any effect would therefore be assumed to be universal
across our population. Pubertal development may affect differ-
ences in BP level owing to stage of sexual maturity, for example,
age of menarche. Although we did not have data on puberty
staging available to include in our analyses, adjustments for age,
sex, height, and weight will at least to some degree indirectly
account for pubertal development. Family history of high BP/
hypertension could not be evaluated, as our electronic clinical
records system set up in 2009 is not mature enough for the
investigation of health outcomes in family pedigrees. We were7also not able to estimate the true prevalence of diabetes in our
population, as we did not have data from an oral glucose
tolerance or HbA1c test. However, we employed high fasting
glucose (>7mmol/L) as indicator of risk of diabetes. Finally,
other studies have stipulated effects of infection (e.g., helminth or
malaria) on BP in children.[18] We did not have any information
on infection status for our population, but because data on this
cohort were collected as part of the MRC Keneba Biobank, all
participants are considered healthy at recruitment. In adults,
hemoglobin level was inversely associated with BP (Tables 1 and
3), which could indicate that underlying nonsymptomatic
infection may be present. However, this effect was not seen in
children and adolescents, and anemia as categorical variable was
not associated with high BP.
Our study also has several strengths. Primarily, with >6000
individuals this represents to our knowledge the largest dataset
on BP across a healthy rural sub-Saharan population covering all
ages above 5 years. We focused our analyses particularly on
children and adolescents <18 years of age and constructed
population-speciﬁc reference percentiles for BP by sex, age, and
height for the ﬁrst time. Furthermore, stored biological samples
collected at the same time as the BP measurement are available
through the MRC Keneba Biobank. Therefore, there is
opportunity to conduct future analyses on blood and urine
biomarkers, which may be indicative of underlying factors
contributing to the observed high prevalence of high BP in this
younger age group, particularly in girls. We are also able to
follow-up these individuals longitudinally, as the KWLPS[24] is a
live prospective cohort, which allows for an integrated system of
research and health care provision for this population. For
instance, we are currently conducting an analysis of the role of
known and putative functional genetic variants affecting high BP/
hypertension based on Illumina HumanExome array data on a
subset of ∼3000 individuals.
Like in other settings across sub-Saharan Africa, rising rates of
hypertension are reported in The Gambia.[3] Stroke and ischemic
heart disease are now counted among the 4th and 7th cause of
death in the WHO African region.[46] However, data from rural
areas and in younger age groups across sub-SaharanAfrica remain
scarce. Recently, a systematic review and meta-analysis protocol
for hypertension prevalence, incidence, and risk factors among
children and adolescents in Africa was published.[47] The authors
highlight that there is considerable variability in the prevalence
estimates for published studies in Southern and Western African
pediatric populations ranging from0%to22.3%.Thiswepropose
is in part because of differences in the deﬁnition of hypertension as
discussed above, emphasizing the need for more consistent
methodological and clinical evaluation of such health outcomes
and/or the application of population-speciﬁc references as we
describe here. As far as we are aware, this is the largest study of its
kind evaluating risk factors for high BP in a rural population in
West Africa. We observe a prevalence of high BP of 8.2% in these
rural children and adolescents, which poses health risks that need
to be addressed urgently given that raised BP in childhood can
aggravate cardiovascular outcomes in later life. Strategies must be
developed particularly in this younger age group to modify
behavior that reduces cardiovascular risk factors (e.g., salt intake)
and to build capacity for maintenance of long-term follow-up and
continued treatment where applicable. Importantly, awareness
also needs to be raised in view of early detection, treatment, and
control of high BP/hypertension, thereby prompting appropriate
policy responses tominimizing disease risks and optimizing related
health outcomes.[28]
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